Literature DB >> 15608307

Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis.

A D Wagner1, J Andresen, E Raum, J Lotz, H Zeidler, J G Kuipers, M C Jendro.   

Abstract

BACKGROUND: Fever of unknown origin (FUO) is a diagnostic challenge. Rheumatologists are often in charge of patients with FUO because the vasculitides, especially, are potential and common causes of FUO.
OBJECTIVE: To evaluate the value of a standardised investigation to identify the cause of FUO.
METHODS: A standardised work-up programme for patients with FUO was started at the beginning of September 1999. The rate of identified causes of FUO was compared between all patients with FUO admitted to a tertiary care centre of rheumatology between January 1996 and August 1999 (control group) and September 1999 and January 2003 (work-up group). In January 2002 magnetic resonance imaging (MRI) was added to the investigation.
RESULTS: 67 patients with FUO were identified--32 before and 35 after institution of the work-up programme. Before implementation 25% of all patients with FUO remained undiagnosed, after implementation 37%. After institution of the investigation the percentage of patients with vasculitides increased significantly from 6% (n = 2) to 26% (n = 9, p = 0.047, Fisher's exact test). This increase could be attributed to the addition of MRI in 2002. When all patients with FUO before 2002 (n = 55) and thereafter (n = 12) were compared the prevalence of systemic vasculitis increased from 11% (n = 6) to 42% (n = 5, p = 0.021).
CONCLUSION: Implementation of a standardised work-up programme for FUO did not improve the overall rate of diagnosis. Addition of MRI significantly increased the diagnosis of systemic vasculitis as the underlying cause of FUO. MRI should be included in the investigation of patients with FUO when vasculitis is suspected.

Entities:  

Mesh:

Year:  2005        PMID: 15608307      PMCID: PMC1755213          DOI: 10.1136/ard.2003.018259

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging.

Authors:  Y H Choe; B K Han; E M Koh; D K Kim; Y S Do; W R Lee
Journal:  AJR Am J Roentgenol       Date:  2000-08       Impact factor: 3.959

Review 2.  Takayasu's arteritis: a changing disease.

Authors:  M Vanoli; G Bacchiani; L Origg; R Scorza
Journal:  J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.902

Review 3.  Fever of unknown origin in the elderly.

Authors:  S Tal; V Guller; A Gurevich; S Levi
Journal:  J Intern Med       Date:  2002-10       Impact factor: 8.989

Review 4.  Polymyalgia rheumatica and giant-cell arteritis.

Authors:  Carlo Salvarani; Fabrizio Cantini; Luigi Boiardi; Gene G Hunder
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

Review 5.  A comprehensive evidence-based approach to fever of unknown origin.

Authors:  Ophyr Mourad; Valerie Palda; Allan S Detsky
Journal:  Arch Intern Med       Date:  2003-03-10

6.  Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.

Authors:  E Reinhold-Keller; A Zeidler; J Gutfleisch; H H Peter; H H Raspe; W L Gross
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

7.  Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis.

Authors:  J Meller; E Grabbe; W Becker; R Vosshenrich
Journal:  Eur Radiol       Date:  2002-06-29       Impact factor: 5.315

Review 8.  Fever of unknown origin in adults: 40 years on.

Authors:  D C Knockaert; S Vanderschueren; D Blockmans
Journal:  J Intern Med       Date:  2003-03       Impact factor: 8.989

9.  Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment.

Authors:  Elisa Tso; Scott D Flamm; Richard D White; Paulo R Schvartzman; Edward Mascha; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2002-06

10.  Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?.

Authors:  Carlo Salvarani; Mauro Silingardi; Angelo Ghirarduzzi; Giovanni Lo Scocco; PierLuigi Macchioni; GianLuigi Bajocchi; Marco Vinceti; Fabrizio Cantini; Ido Iori; Luigi Boiardi
Journal:  Ann Intern Med       Date:  2002-08-20       Impact factor: 25.391

View more
  6 in total

1.  [Magnetic resonance angiography in rheumatology].

Authors:  T A Bley; B Ostendorf; A Scherer; H Kellner; W A Schmidt
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

Review 2.  [Imaging techniques in the evaluation of primary large vessel vasculitides: Part 2: duplex ultrasound, positron emission tomography, computed tomography, and ophthalmological methods].

Authors:  M Both; B Nölle; C von Forstner; F Moosig; W L Gross; M Heller
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

3.  More than meets the eye.

Authors:  Rebecca L Manno; Stuart M Levine; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2010-06-11       Impact factor: 5.532

4.  [Large-vessel vasculitis. Imaging and interventional therapy].

Authors:  M Both; F Moosig; W L Gross; M Heller
Journal:  Radiologe       Date:  2009-10       Impact factor: 0.635

5.  Follow-up CT evaluation of the mural changes in active Takayasu arteritis.

Authors:  Sang Young Kim; Jae Hyung Park; Jin Wook Chung; Hyo Cheol Kim; Whal Lee; Young Ho So; Hwan Jun Jae
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

6.  18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin.

Authors:  Karel-Jan D F Lensen; Alexandre E Voskuyl; Conny J van der Laken; Emile F I Comans; Dirkjan van Schaardenburg; Alex B Arntzenius; Ton Zwijnenburg; Frank Stam; Michelle Gompelman; Friso M V D Zant; Anneke Q A van Paassen; Bert J Voerman; Frits Smit; Sander Anten; Carl E Siegert; Arjen Binnerts; Yvo M Smulders
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.